Former Marine, MIT Ph.D., and AI innovator—Dr. Yu-Feng Wei is revolutionizing industries with Causal AI! In 2014, alongside Stanford economist Dr. Hung-Ken Chien, Dr. Wei co-founded Vizuro, bringing cutting-edge Multimodal Causal GenAI technology to life. This game-changing platform tackles complex challenges like sales prediction, drug discovery, and biomarker development by uncovering hidden causalities in multimodal data.

"Through Multimodal Causal GenAI, we can address highly complex problems, such as marketing strategies and biological mechanisms. From fundamental research to drug development and healthcare technology, this powerful tool opens up endless possibilities," says Dr. Wei.

Partnering with Pharma giants like Roche, Takeda, PharmaEssentia, and ACT Genomics, Vizuro is redefining digital transformation in biotech, creating AI-driven workflows for sales, diagnostics, and more.

Dr. Wei's Journey:
From designing Boeing 787 analytics during his MIT Ph.D. to founding Vizuro, his 20+ years in AI-driven solutions span healthcare, manufacturing, and life sciences. Now leading Taiwan’s Vizuro TAIWAN, Dr. Wei continues to bridge global innovation with local expertise, propelling biotech into the AI era.

Join the movement redefining biotech and beyond!

Learn more: Vizuro Story
https://news.gbimonthly.com/tw/magazine/article_show.php?num=63847

Follow #GlobalBio for updates on AI-driven breakthroughs!

#AIInBiotech #CausalAI #Innovation #BiotechRevolution #Vizuro #GlobalLeaders